128P Neoadjuvant durvalumab plus chemotherapy in stage III non-small cell lung cancer: A phase II single-center exploratory study. (December 2022) - Dong, X.; Tong, F.; Zhang, R.; Liang, B.; Zhai, W.; Wang, S.; Fan, J.; Wang, Y.; Huang, Y.